Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / India - Page 3

India

COVISHIELD completed enrollment of phase III clinical trials under partnership of ICMR and Serum Institute
Biotechnology | Infectious Disease | Vaccine

COVISHIELD completed enrollment of phase III clinical trials under partnership of ICMR and Serum Institute

On Nov. 11, 2020, the Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) announced…

Read More COVISHIELD completed enrollment of phase III clinical trials under partnership of ICMR and Serum InstituteContinue

Mateon and Windlas Biotech announced agreement to commercialize ARTIVEDA against COVID-19
Biotechnology | COVID-19 | Therapeutics

Mateon and Windlas Biotech announced agreement to commercialize ARTIVEDA against COVID-19

On Nov. 11, 2020, Mateon Therapeutics announced an agreement with Windlas Biotech of India to commercialize ARTIVeda. ARTIVeda…

Read More Mateon and Windlas Biotech announced agreement to commercialize ARTIVEDA against COVID-19Continue

IAVI, Merck, and Serum Institute joined forces to develop monoclonal antibodies for COVID-19
COVID-19 | Life Science History

IAVI, Merck, and Serum Institute joined forces to develop monoclonal antibodies for COVID-19

On Oct. 22, 2020, IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges,…

Read More IAVI, Merck, and Serum Institute joined forces to develop monoclonal antibodies for COVID-19Continue

Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19
Biotechnology | COVID-19 | Therapeutics

Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19

On Oct. 7, 2020, Mateon Therapeutics announced the first patient enrolled this week in its Phase IV study…

Read More Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19Continue

Mateon initiated commercialization of Artshield
COVID-19 | Therapeutics

Mateon initiated commercialization of Artshield

On Oct. 5, 2020, Mateon Therapeutics announced that ArtiShieldTM had been approved for manufacture and marketing by the…

Read More Mateon initiated commercialization of ArtshieldContinue

COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
COVID-19 | Life Science History | Vaccine

COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India

On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…

Read More COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and IndiaContinue

Serum Institute to produce additional 100 million Covid-19 vaccine doses for India and low-and middle-income countries
COVID-19 | Life Science History | Vaccine

Serum Institute to produce additional 100 million Covid-19 vaccine doses for India and low-and middle-income countries

On Sept. 29, 2020, a further collaboration among the Serum Institute of India (SII), Gavi and the Bill…

Read More Serum Institute to produce additional 100 million Covid-19 vaccine doses for India and low-and middle-income countriesContinue

ViroVax licensed adjuvant to be used in India’s first COVID-19 vaccine in human trials
Biotechnology | COVID-19 | Life Science History | Vaccine

ViroVax licensed adjuvant to be used in India’s first COVID-19 vaccine in human trials

On Sept. 28 2020, ViroVax announced that it had licensed its adjuvant, Alhydroxiquim-II, to Bharat Biotech International, an…

Read More ViroVax licensed adjuvant to be used in India’s first COVID-19 vaccine in human trialsContinue

Serum Institute initiated manufacturing of Codagenix’s intranasal live-attenuated COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Serum Institute initiated manufacturing of Codagenix’s intranasal live-attenuated COVID-19 vaccine candidate

On Sept. 22, 2020, Codagenix announced that the Serum Institute of India has begun manufacturing CDX-005, the company’s…

Read More Serum Institute initiated manufacturing of Codagenix’s intranasal live-attenuated COVID-19 vaccine candidateContinue

Novavax announced COVID-19 vaccine manufacturing agreement with Serum Institute of India
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax announced COVID-19 vaccine manufacturing agreement with Serum Institute of India

On Sept. 15, 2020, Novavax announced an amendment to its existing agreement with Serum Institute of India which…

Read More Novavax announced COVID-19 vaccine manufacturing agreement with Serum Institute of IndiaContinue

Mateon global study for Artemisinin intervention against COVID-19 cleared for patient enrollment in India
Biotechnology | COVID-19 | Therapeutics

Mateon global study for Artemisinin intervention against COVID-19 cleared for patient enrollment in India

On Sept. 14, 2020, Mateon Therapeutics announced that its global study based on its ARTI-19 protocol for Artemisinin…

Read More Mateon global study for Artemisinin intervention against COVID-19 cleared for patient enrollment in IndiaContinue

Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Therapeutics | Vaccine

Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute

On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…

Read More Novavax signed COVID-19 vaccine supply deal with India’s Serum InstituteContinue

Mateon and Abiogenesis to initiate clinical study to test Artemisinin as a treatment for COVID-19 in India
Biotechnology | COVID-19 | Life Science History | Therapeutics

Mateon and Abiogenesis to initiate clinical study to test Artemisinin as a treatment for COVID-19 in India

On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they had initiated a ARTI-19 randomized, controlled, multi-site India…

Read More Mateon and Abiogenesis to initiate clinical study to test Artemisinin as a treatment for COVID-19 in IndiaContinue

Serum Institute of India received approval to start human trials for Oxford vaccine
Biotechnology | Infectious Disease | Nanotechnology | Vaccine

Serum Institute of India received approval to start human trials for Oxford vaccine

On Aug. 1, 2020, Novavax announced it had received approval to start human trials in India for the…

Read More Serum Institute of India received approval to start human trials for Oxford vaccineContinue

Serum Institute conducted phase III clinical trial of BCG vaccine
COVID-19 | Life Science History | Vaccine

Serum Institute conducted phase III clinical trial of BCG vaccine

On Jul. 27, 2020, the Serum Institute of India announced that it was is conducting phase III clinical…

Read More Serum Institute conducted phase III clinical trial of BCG vaccineContinue

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine

On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…

Read More The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccineContinue

Philips introduced first-of-a-kind mobile ICUs in India to tackle COVID-19 and other emergencies
Life Science History

Philips introduced first-of-a-kind mobile ICUs in India to tackle COVID-19 and other emergencies

On Jul. 7, 2020, Royal Philips announced it had introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India….

Read More Philips introduced first-of-a-kind mobile ICUs in India to tackle COVID-19 and other emergenciesContinue

Fujifilm partnered with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
COVID-19 | Pharmaceutical | Therapeutics

Fujifilm partnered with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan

On Jul. 1, 2020, FUJIFILM announced a partnership with Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered in…

Read More Fujifilm partnered with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of JapanContinue

Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trials
COVID-19 | Infectious Disease | Vaccine

Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trials

On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…

Read More Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trialsContinue

Symbiosis and AstraZeneca signed supply agreement for sterile manufacture of COVID-19 vaccine for clinical trials
COVID-19 | Life Science History | Vaccine

Symbiosis and AstraZeneca signed supply agreement for sterile manufacture of COVID-19 vaccine for clinical trials

On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…

Read More Symbiosis and AstraZeneca signed supply agreement for sterile manufacture of COVID-19 vaccine for clinical trialsContinue

Pneumonia vaccine price dropped dramatically for lower-income countries thanks to the Gavi pneumococcal Advance Market Commitment
Life Science History | Vaccine

Pneumonia vaccine price dropped dramatically for lower-income countries thanks to the Gavi pneumococcal Advance Market Commitment

On Jun. 16, 2020, lower-income countries across the world have access life-saving pneumococcal conjugate vaccines, which protect against…

Read More Pneumonia vaccine price dropped dramatically for lower-income countries thanks to the Gavi pneumococcal Advance Market CommitmentContinue

AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityメs vaccine at no profit
COVID-19 | Life Science History | Vaccine

AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityメs vaccine at no profit

On Jun. 13, 2020, AstraZeneca announced an agreement with Europeメs Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…

Read More AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityメs vaccine at no profitContinue

Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for Remdesivir
Biotechnology | COVID-19 | Therapeutics

Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for Remdesivir

On Jun. 13, 2020, Dr. Reddy’s Laboratories announced that it had entered into a non-exclusive Licensing Agreement with…

Read More Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for RemdesivirContinue

HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries
Life Science History | Vaccine

HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries

On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…

Read More HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countriesContinue

HPV vaccine manufacturers committed to immunise at least 84 million girls in Gavi countries
Life Science History | Vaccine

HPV vaccine manufacturers committed to immunise at least 84 million girls in Gavi countries

On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India (SII) and Walvax pledged to…

Read More HPV vaccine manufacturers committed to immunise at least 84 million girls in Gavi countriesContinue

AstraZeneca announced next steps towards broad and equitable access to Oxford Universitys COVID-19 vaccine
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics | Vaccine

AstraZeneca announced next steps towards broad and equitable access to Oxford Universitys COVID-19 vaccine

On Jun. 4, 2020, AstraZeneca announced the next steps in its commitment to broad and equitable global access…

Read More AstraZeneca announced next steps towards broad and equitable access to Oxford Universitys COVID-19 vaccineContinue

Slower clearance of Coronavirus infection may explain why men fare worse than women
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | Therapeutics

Slower clearance of Coronavirus infection may explain why men fare worse than women

On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…

Read More Slower clearance of Coronavirus infection may explain why men fare worse than womenContinue

Long-term analysis showed GM cotton no match for insects in India
Life Science History

Long-term analysis showed GM cotton no match for insects in India

On Mar. 13, 2020, Washington University in St. Louis announced the first long-term study of Bt cotton impacts…

Read More Long-term analysis showed GM cotton no match for insects in IndiaContinue

New pneumococcal vaccine from Serum Institute of India achieved WHO prequalification
Biotechnology | Vaccine | WHO

New pneumococcal vaccine from Serum Institute of India achieved WHO prequalification

On Dec. 19, 2019, the WHO announced that PNEUMOSIL, a vaccine against a leading cause of deadly childhood…

Read More New pneumococcal vaccine from Serum Institute of India achieved WHO prequalificationContinue

The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands Government
Biotechnology | Therapeutics | Vaccine

The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands Government

On Jul. 4, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…

Read More The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands GovernmentContinue

Page navigation

Previous PagePrevious 1 2 3 4 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search